在Pfizer mRNABNT162b2 (Comirnaty®) 接种COVID-19疫苗后,泛起性喷发性角质瘤 (GEKA) 成功使用Cemiplimab治疗了COVID-19疫苗
Proietti Ilaria1, Skroza Nevena1, Tolino Ersilia1
1Dermatology Unit "Daniele Innocenzi", "A. Fiorini" Hospital, via Firenze, 1, 04019 Terracina, Italy.
Viruses
|August 29, 2024
概括
接种COVID-19疫苗可能会引发泛起性喷发性角瘤 (GEKA),这是一种罕见的皮肤疾病. 这项案例研究表明,塞米普利马布有效治疗了与疫苗相关的GEKA,这表明免疫检查点抑制剂是潜在的治疗方法.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 广泛推出COVID-19疫苗,包括瑞的mRNA BNT162b2 (Comirnaty®),始于2020年12月.
- 疫苗接种后有各种皮肤反应的记录.
- 角质瘤通常是良性皮肤瘤,但罕见的变种可以呈现出侵略性.
相关概念视频
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347


